Early research (Phase 1)Study completedNCT02273531
What this trial is testing
Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers
Who this might be right for
Healthy
Boehringer Ingelheim 24